NCT04678518View on ClinicalTrials.gov

Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

December 31, 2023

Conditions
Inflammatory Markers Changes in Response to Extra-corporeal Membrane Oxygenator Decannulation
Interventions
DIAGNOSTIC_TEST

Inflammatory makers that will include Interleukins (IL); IL1, IL2, IL6 and TNF

1 hour before decannulation and 3 times after decannulation (1 hours, 12 hours and 24 hours)

Trial Locations (2)

3050

RECRUITING

Hamad medical corporation, Doha

RECRUITING

Hamad medical corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT04678518 - Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation | Biotech Hunter | Biotech Hunter